Southeastern Asset Management Inc Biogen Inc. Transaction History

Southeastern Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $158 Million - $188 Million	-842,962 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $3.02 Million - $3.8 Million	-15,561 Reduced 1.81%	842,962 $178 Million
Q4 2021 Feb 15, 2022	BUY	$223.92 - $287.77 $192 Million - $247 Million	858,523 New	858,523 $206 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $156 Million - $250 Million	-603,890 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $147 Million - $172 Million	603,890 New	603,890 $169 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Southeastern Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Southeastern Asset Management Inc with notifications on news.